LCG Talks Coffee Mornings EP7 | Robert Jappie, Partner at Ince, Cannabis Law and Regulation

LCG Talks Coffee Mornings EP7 | Robert Jappie, Partner at Ince, Cannabis Law and Regulation

Robert Jappie is a Partner at Ince, specialising in Cannabis Law and Regulation. Since he led the UK’s first dedicated Cannabis Law department in May 2018, Robert has become a well-respected legal expert within Europe’s fast-growing cannabis industries. He currently acts for several established CBD brands, Licensed Producers, Medicinal Cannabis companies and distributors, advising on the full range of regulatory and commercial issues facing the sector. As a result, Robert has become the leading legal authority on the developing regulatory environment both here in the UK and in Europe.

In March 2019, Robert travelled to Brussels to present alongside counsel to the European Commission’s working group on Novel Foods on behalf of the UK CBD industry. He has also been involved in regulatory challenges to widen patient and consumer access to cannabis derived products.

From his previous work at Release and with ten years prior experience as a criminal defence litigator, Robert has a unique insight into the complexities of global drug policy, life sciences regulation and proceeds of crime related matters.

You can watch the LCG Talks Coffee Morning with Robert Jappie here.

In this week’s episode of LCG Talks Coffee Mornings, Robert kicks off by talking about the FSA Novel Foods regulations, including advice to non-UK brands looking to enter the UK market and whether COVID-19 has affected the deadline or process for CBD brands applying for Novel Foods.

Robert also discusses current marketing restrictions for CBD and how to overcome this and links these two topics together by sharing his thoughts on whether  the Novel Food regulations and approved brands will allow more mainstream marketing for CBD?

Other topics discussed include:

  • Greater access to Medical Cannabis and if access to Medical Cannabis will  increase in a post COVID World
  • The effects of Brexit and if this will open up the Medical Cannabis market
  • CBD/Hemp Flower legalities

 

Matters Worked On:

Provacan – regulatory and commercial support for one of the leading CBD brands.

CanXchange – a CBD and Medicinal Cannabis trading platform, on their regulatory compliance.

Natuera (owned by Cronos Group) – a Colombian Licensed Producer, on regulatory compliance for their European expansion.

Pleasant Lands Campaign by Volteface – Legal Advisor to the campaign to open up hemp farming in the UK.

Ignite – regulatory and commercial advice for their UK CBD launch in July 2019

 

Articles:

https://issuu.com/hempandcbdmag/docs/h_cbdfeb2020_150dpiwebpdf/s/10187159

https://newfrontierdata.com/cannabis-insights/uk-marketing-challenges-persist-for-cbd/

https://www.incegd.com/en/news-insights/cbd-and-novel-foods-devil-detail

Social Media:

https://www.linkedin.com/in/robert-jappie-cannabislaw/

Twitter: @RobJappie

 

Please use this link to register to watch the next episode live: https://us02web.zoom.us/meeting/register/tZUvfuqgqD8jHNCivX4xJ6I8Cp_h-QXpWC5-